Pegavision Q4 2025 Financials
Key facts
- Pegavision Q4 2025 Financials
- Pegavision Corporation (stock code: 6491), a biotechnology and medical care company, reported a basic EPS of NT0.87 for Q4 2025. The company's revenue reached NT.039 billion, with a net income after tax of NT.650 billion.
- Source: PR Times
- Date: December 1, 2025
Direct answer
Pegavision Corporation (stock code: 6491), a biotechnology and medical care company, reported a basic EPS of NT0.87 for Q4 2025. The company's revenue reached NT.039 billion, with a net income after tax of NT.650 billion.
- Citation
- Pegavision Q4 2025 Financials (December 1, 2025), PR Times
- Source
- PR Times
- Date
- December 1, 2025
Pegavision Corporation (stock code: 6491), a biotechnology and medical care company, reported a basic EPS of NT0.87 for Q4 2025. The company's revenue reached NT.039 billion, with a net income after tax of NT.650 billion.
📋 Article Processing Timeline
- 📰 Published: December 1, 2025 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (3047h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:21 (16h 20m after Collected)
FAQ
What are the key facts in this article?
Pegavision Corporation (stock code: 6491), a biotechnology and medical care company, reported a basic EPS of NT0.87 for Q4 2025. The company's revenue reached NT.039 billion, with a net income after tax of NT.650 billion.
What is the direct answer?
Pegavision Corporation (stock code: 6491), a biotechnology and medical care company, reported a basic EPS of NT0.87 for Q4 2025. The company's revenue reached NT.039 billion, with a net income after tax of NT.650 billion.
What is the source and date?
PR Times: https://openapi.twse.com.tw/financial/twse-fin-6491-2025Q4 | December 1, 2025